Patrick Kaminker is a seasoned expert in translational medicine and oncology, currently serving as the Director of Translational Medicine at Full-Life Technologies since November 2025. Prior to this role, Patrick held significant positions including Director of Translational Biology at MacroGenics, Inc. and Associate Director of Oncology at Zymeworks Inc., contributing to the development of key oncology pipeline products and biomarkers. Patrick's earlier experience includes roles as Principal Research Scientist at AbbVie, where involvement centered around oncology therapeutics, and Senior Scientist at Human Genome Sciences, focusing on antibody-drug conjugate programs. Notable positions also include Senior Scientist at Celera Corporation, Staff Scientist at the Buck Institute for Research on Aging, and Postdoctoral Scientist at Berkeley Lab. Patrick earned a PhD in Pharmacology from the University of Kentucky College of Medicine and a BS in Microbiology from the University of Florida.
This person is not in any teams
This person is not in any offices